menu
    • menu

    Company profile for Arch Biopartners

    NEW Drugs in Dev: 5
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arch Biopartners Inc. is focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch works closely with the scientific community, universities and research institutions to advance and build the value of select preclinical technologies, develop the most promising intellectual property, and create value for its investors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arch BiopartnersCanada Flag
    Country
    Country
    Canada
    Address
    Address
    27 St. Clair Avenue East P.O. Box 305 Toronto, Ontario, M4T 2M5 Canada
    Telephone
    Telephone
    +1 647 428 7031
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://archbiopartners.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arch-biopartners-inc-foiff-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/archbiopartners

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arch Biopartners Arranges Non-Brokered Private Placement
    Arch Biopartners Arranges Non-Brokered Private Placement

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264427/0/en/Arch-Biopartners-Arranges-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Arch Biopartners, Fraser Health Sign Phase II Cardiac AKI Trial
    Arch Biopartners, Fraser Health Sign Phase II Cardiac AKI Trial

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261381/0/en/Arch-Biopartners-and-the-Fraser-Health-Authority-enter-into-a-Clinical-Trial-Agreement-for-the-Phase-II-Cardiac-Surgery-Associated-AKI-Trial.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Arch Bio Begins Phase 2 CS-AKI Trial At St. Michael's Hospital
    Arch Bio Begins Phase 2 CS-AKI Trial At St. Michael's Hospital

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259672/0/en/Arch-Biopartners-Announces-St-Michael-s-Hospital-Commences-Patient-Dosing-in-the-Phase-II-CS-AKI-Trial-of-LSALT-Peptide.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share
    Arch Bio Scientists Link IL-32 To Inflammation In Diabetic
    Arch Bio Scientists Link IL-32 To Inflammation In Diabetic

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234424/0/en/Arch-Biopartners-Scientists-Publish-New-Data-Linking-the-Cytokine-IL-32-to-Inflammation-and-Diabetic-Kidney-Disease.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Arch Bio Appoints Dr. Patrick Vink As Board Chairman
    Arch Bio Appoints Dr. Patrick Vink As Board Chairman

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220303/0/en/Arch-Biopartners-Announces-Appointment-of-Dr-Patrick-Vink-as-Chairman-of-the-Board.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Arch Bio Gets Ethics Approval For St. Michael's In Phase II
    Arch Bio Gets Ethics Approval For St. Michael's In Phase II

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206122/0/en/Arch-Biopartners-Announces-Ethics-Approval-for-St-Michael-s-Hospital-to-Participate-in-the-Phase-II-Cardiac-Surgery-Associated-AKI-Trial-for-LSALT-Peptide.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search